Stock Events

Stock Events

Biocryst Pharmaceuticals (BCRX) Q2 2024 Earnings

6MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.31

-0.26

-0.22

-0.17

Details

Expected EPS

-0.209349

Actual EPS

-0.17

Surprise EPS

0.04

Surprise Percent

+18.8%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.17 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.